Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia

Havelange V, Demoulin JB

Journal of Blood Medicine 2013, 4:111-121

Published Date: 9 August 2013